Comparative Analysis of CA-IX, p16, Proliferative Markers, and Human Papilloma Virus (HPV) in the Diagnosis of Significant Cervical Lesions in Patients with a Cytologic Diagnosis of Atypical Glandular Cells (AGC)
This research trial studies carbonic anhydrase 9 (CA-IX), p16, proliferative markers, and
human papilloma virus (HPV) in diagnosing cervical lesions in patients with abnormal cervical
cells. Studying biomarkers in abnormal cervical cells may improve the ability to find
cervical lesions and plan effective treatment.
View more details from ClinicalTrials.gov.
For more information about a clinical trial, clinical trial eligibility, or informed consent, contact our research nurses by phone or email:
Please Note: Any eligibility criteria noted are subject to change. Our research nurses can provide you with the most current eligibility and exclusion criteria. Any study involvement to be undertaken must ultimately be determined on an individual basis.